Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023Business Wire • 05/17/23
Gilead Sciences, Inc. (GILD) Presents at RBC Capital Markets Global Healthcare Conference (Transcript)Seeking Alpha • 05/16/23
Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in InflammationBusiness Wire • 05/15/23
Gilead Sciences, Inc. (GILD) Presents at BofA Securities 2023 Health Care Conference (Transcript)Seeking Alpha • 05/13/23
Gilead Sciences didn't violate government patents on HIV prevention treatment, jury findsCNBC • 05/09/23
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinTheraBusiness Wire • 05/09/23
CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)Business Wire • 05/04/23
Gilead Posts Bullish Cancer Drug Sales, But Profit Questions LingerInvestors Business Daily • 04/27/23